Silent Threat: What Every Veterinarian Needs to Know About Sloth Fever, the Emerging Oropouche Virus
As a veterinary professional, you're likely familiar with the major zoonotic diseases that pose risks to both animals and humans. However, a lesser-known but increasingly significant threat is emerging from the tropical regions of South and Central America—the Oropouche virus (OROV). This arbovirus, primarily transmitted by biting midges, has the potential to cause widespread illness, not just in human populations but also with implications for animal health and veterinary practices. Oropouche virus is spread to people primarily by the bite of infected biting midges (a type of small fly) and mosquitoes. According to the CDC, the virus is transmitted in forested areas between mosquitoes and non-human vertebrate hosts such as birds, rodents and sloths, which is where its nickname is derived.
Veterinary Medicine in Crisis? Discover the Club That’s Bringing It Back to Life!
Club 250 will make its debut at AAHA CON 2024 on September 12th in National Harbor, Maryland. Don’t miss this opportunity to learn from the best and gain the tools you need to assess, treat, and revitalize your practice. With the insights and strategies provided by Club 250, you can ensure your veterinary practice is not just surviving the challenges ahead but thriving for years to come. Check it out here: https://www.aaha.org/events/aaha-con/
Penn State Dairy Herd Certified Free of Avian Influenza After Rigorous Testing
Penn State’s dairy herd has been certified as free of highly pathogenic avian influenza (HPAI) after three weeks of intensive testing, according to animal health experts from the College of Agricultural Sciences. The certification was achieved under the Pennsylvania Lactating Dairy Cow Health Monitoring Program, a voluntary state initiative aimed at monitoring and preventing the spread of HPAI in dairy cattle.
Adora Animal Health Secures First U.S. Patent, Advancing Development of Generic PSGAG for Veterinary Use
Franklin-based Adora Animal Health Corporation (Adora) has announced the publication of its first U.S. patent, US Patent 12,059,430. This significant milestone relates to innovative processes developed by Adora to produce a purified form of the active ingredient in its injectable veterinary generic PSGAG (Polysulfated Glycosaminoglycan), which is widely recognized under the brand name Adequan, marketed by American Regent.
Elanco Animal Health Expands Kansas Facility to Meet Rising Global Demand
Elanco Animal Health is set to significantly enhance its production capabilities with the expansion of its Kansas manufacturing facility. This strategic investment is part of Elanco’s broader initiative to bolster its supply chain and accommodate the growing global demand for its animal health products. The Kansas facility, a key component of Elanco’s production network, will receive substantial infrastructure upgrades aimed at increasing production efficiency and capacity.
Zoetis, IDEXX, and Weave Report Strong Q2 2024 Earnings, Announce Growth Strategies
The veterinary and healthcare sectors saw significant activity this quarter as Zoetis, IDEXX Laboratories, and Weave all reported robust financial results, underscoring their continued growth and strategic advancements.

